ExploreWatchlistsPricing
  1. JP-listed companies
  2. Linical Co., Ltd.
  3. Financials
  4. Retained earnings

Linical Co., Ltd. (2183)

Market cap
¥5.1B
P/E ratio
25.7x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Mar 31, 20262,746-57.34%
Mar 31, 20256,437-12.00%
Mar 31, 20247,315+0.30%
Mar 31, 20237,293+10.42%
Mar 31, 20226,605+7.52%
Mar 31, 20216,143+3.64%
Mar 31, 20205,927+3.71%
Mar 31, 20195,715+5.90%
Mar 31, 20185,397+24.68%
Mar 31, 20174,328+39.23%
Mar 31, 20163,109+46.61%
Mar 31, 20152,120

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat